Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes

Investigational Site Number : 3920015, Ichikawa, Chiba, Japan

Investigational Site Number : 3920006, Sapporo, Hokkaido, Japan

Investigational Site Number : 3920018, Kobe, Hyōgo, Japan

Investigational Site Number : 3920007, Yahaba, Iwate, Japan

Investigational Site Number : 3920019, Yokohama, Kanagawa, Japan

Investigational Site Number : 3920001, Iruma, Saitama, Japan

Investigational Site Number : 3920010, Chūō, Yamanashi, Japan

Investigational Site Number : 3920017, Fukuoka, Japan

Investigational Site Number : 3920016, Kyoto, Japan

Investigational Site Number : 3920004, Osaka, Japan

Investigational Site Number : 3920020, Tokyo, Japan